Who are SODIUM PROPIONATE's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): chlorobutanol, hexetidine, Benzalkonium chloride (BAK).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-propionate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

SODIUM PROPIONATE — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SODIUM PROPIONATE (SODIUM PROPIONATE) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial preservative. Area: Metabolic.

marketed Antimicrobial preservative Carbonic anhydrase, Free fatty acid receptor 3 Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

SODIUM PROPIONATE (SODIUM PROPIONATE). Sodium propionate acts as an antimicrobial agent by disrupting the cell wall and metabolic processes of microorganisms.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
SODIUM PROPIONATE TARGET	SODIUM PROPIONATE		marketed	Antimicrobial preservative	Carbonic anhydrase, Free fatty acid receptor 3
chlorobutanol, hexetidine	chlorobutanol, hexetidine	Federico II University	marketed	Antimicrobial preservative / topical antiseptic
Benzalkonium chloride (BAK)	Benzalkonium chloride (BAK)	Gangnam Severance Hospital	marketed	Quaternary ammonium compound / Antimicrobial preservative

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial preservative class)

· 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SODIUM PROPIONATE — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-propionate. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing